Second negative report hits Intuitive Surgical, but shares rally on positive Goldman Sachs update Wall Street Beat

Shares of Intuitive Surgical (NSDQ:ISRG) came under pressure early yesterday on a negative report from hedge fund Citron Research, before rallying after Goldman Sachs boosted its price target on the stock.

"As Wall St. awaits ISRG earnings next week, which are at risk of tipping weakness in its total procedures growth, the real story is the macro picture, which portends enormous headwinds in 2013 for the 1-time Wall Street darling. Procedure counts will dramatically soften and new machines sales will flatline, due to:
heightened awareness of treatment cost differentials to be leveled under Obamacare; the consequences of looming litigation, which will force hospitals to disclose more completely and accurately the risks of complications in robotic surgeries, including: the specific risks of being exposed to the movements of the robot’s instruments; the electricity conducted within and through them; and the surgeon’s level of skill and training in manipulating the device," according to the Citron report.

Sign up to get our free newsletters delivered straight to your inbox

That sent ISRG shares down 2.5% yesterday to a low of $485.80 (a December Citron report sent shares down 10%).

But a positive update from Goldman Sachs, based on an unrevealed new product from Intuitive, sent shares to a peak of $517.46 before closing at $514.20, up 3.1% for the day.

"While not yet announced, a new system iteration (the most recent was da Vinci Si in 2009) as well as uptake of expanded device add-ons (i.e. EndoWrist vessel sealer, stapler system, dual consoles) could be a driver of new growth," according to Goldman Sachs. "We see ISRG’s relative safety profile as an attractive alternative when compared to other surgical options. Additionally the company’s strong cash and investment holdings ($3.3 billion as of 3Q12) and significant free cash flow generation (we estimate $800+ million for 2013E) should be more than sufficient to settle any legal proceedings with plenty of room to spare."

 Shire’s VC arm drums up a coll $20M
Shire Investments LLC, the venture investing arm of British biotech Shire (NSDQ:SHPGY), raised $20 million in an equity round.
Read more

 American Taxpayer Relief Act pares $4k from AMS Gamma Knife treatments
The American Taxpayer Relief Act of 2012 included a provision that slashes Medicare’s reimbursement for American Shared Hospital Services‘s (NYSE:AMS) Gamma Knife procedures by approximately $4,000 each, effective April 1. AMS shares were down 1.3% to $2.29 apiece as of about 3 p.m. today.
Read more

 Pyng Medical investor makes takeover bid
Pyng Medical (CVE:PYT) said 1 of its investors, Excelera Corp., plans to make a cash offer for a majority of its shares. Excelera owns a 17.7% stake in Pyng.
Read more

 Vycor Medical runs 1-150 reverse stock split
Vycor Medical (OTC:VYCO) effected a 1-150 reverse stock split, turning some 857.2 million shares into 5.7 million and boosting prices from 1¢ apiece to $1.16 each as of about 2 p.m. today.
Read more

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): UBS maintains "buy" rating, lowers price target to $38.
  • Intuitive Surgical (NSDQ:ISRG): Goldman Sachs maintains "neutral" rating, raises price target from $561 to $587.
  • Mako Surgical (NSDQ:MAKO): Leerink Swann maintains “market perform” rating, lowers price target to $12-13 from $15.
  • Medtronic (NYSE:MDT): Credit Suisse upgrades from "neutral" to "outperform", sets $50 price target.
  • Stryker (NYSE:SYK): Leerink Swann maintains "outperform" rating, ~$61 price target.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply